Colonoscopy or Fecal Occult Blood Test in Screening Healthy Participants for Colorectal Cancer

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

4,952

Participants

Timeline

Start Date

May 31, 2000

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Colorectal Cancer
Interventions
PROCEDURE

annual screening

Participants with negative baseline FOBT undergo FOBT annually for up to 4 years in the absence of a positive FOBT

PROCEDURE

fecal occult blood test

Participants undergo a baseline fecal occult blood test (FOBT)

PROCEDURE

screening colonoscopy

Patients undergo baseline screening colonoscopy

PROCEDURE

standard follow-up care

Standard care

Trial Locations (4)

10065

Memorial Sloan-Kettering Cancer Center, New York

55455

Masonic Cancer Center at University of Minnesota (Data collection only), Minneapolis

71130-3932

Feist-Weiller Cancer Center at Louisiana State University Health Sciences, Shreveport

98101-1466

Kaiser Permanente Washington Health Research Institute (Data collection only), Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER